PDRM

Paul MacLeman

[islandpharmaceuticals @IslandPharma]

.@IslandPharma is looking forward to joining other global #biotech and #science leaders at next week’s @IAmBiotech #BIO2023 in Boston. Anyone interested in meeting with $ILA during the event, should email [email protected]

#antiviral #infectiousdisease #denguefever

[Alastair Hick @alastair_hick]

Govt to standardise university commercialisation contracts. Consultation out now. If you work with universities on research or commercialisation then you should read this and consider a submission. https://t.co/hdChnORpNz

[PDRM @pmacleman]

SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria https://t.co/nRUqOyzpsq via @Yahoo

[AdAlta Limited @AdAlta1AD]

Learn more about how @CarinaBiotech and AdAlta are collaborating to develop i-body enabled, precision engineered CAR-T cell therapies that provide new hope for #cancer patients. https://t.co/AxfKgURMq4

#CAR-T $1AD #ausbiz

[islandpharmaceuticals @IslandPharma]

It is worth remembering on #WorldMosquitoDay that the mosquito, which transmits viruses such as #dengue, #Zika and others, remains one of the most dangerous creatures in the world. $ILA is focused on developing molecules for the prevention & treatment of mosquito-borne viruses

[TALi @TALiHealth]

Excited to announce @akililabs will license TALi's technology designed to address early childhood attention impairments.
With our shared focus on clinical validation & user experience, we will continue to revolutionise treatment of children with #ADHD.
https://t.co/QDbm0oOaPA

[islandpharmaceuticals @IslandPharma]

Island Pharmaceuticals (ASX:ILA) granted Australian patent for Dengue treatment https://t.co/isDKaeca7l via @themarketherald #ausbiz #trials #dengue #ILA $ILA

[islandpharmaceuticals @IslandPharma]

.@IslandPharma lead asset, ISLA-101 granted a key patent entitled “Method of Viral Inhibition” from @IPAustralia covers a method of treating or preventing #Dengue & other mosquito borne #viruses. $ILA has licensed the IP portfolio, generated by @MonashUni
https://t.co/1CkaLaaWEs

[islandpharmaceuticals @IslandPharma]

Island Pharmaceuticals shares gain on patent https://t.co/czhdbU41fk
$ILA #dengue

[islandpharmaceuticals @IslandPharma]

India continues to be plagued with not one virus but with both SARS-CoV-2 #COVID19 & #dengue, complicating care for those infected individuals. This highlights the need for continued work to develop therapies to combat these viral outbreaks. $ILA
https://t.co/48eD2JDmXa

[islandpharmaceuticals @IslandPharma]

2 new cases of #Dengue in the Cook Islands brings the total to near 217 confirmed & probable cases during the 6mth outbreak. The outbreak highlights the difficulties in eradicating the #virus & supports the continued need for medical intervention. https://t.co/512pXsNHxe

[islandpharmaceuticals @IslandPharma]

Island Pharmaceuticals jumps 8.5% https://t.co/pe5lvrQJds

[AdAlta Limited @AdAlta1AD]

Watch @TimOldhamAU, @AdAlta1AD CEO & MD, discuss the results of Phase I trials of AD-214 & plans to develop an inhaled version of its first in class anti-fibrotic, AD-214, for Idiopathic Pulmonary
Fibrosis IPF https://t.co/Luiewbqa3y
#IPF $1AD #ausbiz

[islandpharmaceuticals @IslandPharma]

We are pleased to announce @IslandPharma has secured drug substance for its #dengue fever clinical trials faster than expected shortens the timeline to ISLA-101 clinical trials. $ILA will purchase material from CerRx & @CuriaCDMO will process the GMP API https://t.co/NhYpdJH2sn

[AdAlta Limited @AdAlta1AD]

.@Edison_Inv_Res issued new coverage highlighting $1AD’s decision to progress to an inhaled formulation of AD-214 into efficacy studies in patients with idiopathic #pulmonary #fibrosis. Valuation unchanged at A$68m or A$0.28/share Full report https://t.co/M5X4Womc4w @EdisonHealth

[AdAlta Limited @AdAlta1AD]

Coverage in the latest Bioshares update highlighting Adalta Progress with its @GEHealthcare Collaboration and focused on $1AD clear pathway to future milestones. https://t.co/WB20BZSNUE #Fibrosis #IPF#ILD #ausbiz

[AdAlta Limited @AdAlta1AD]

Pitt Street Research Update highlighting @AdAlta1AD's GE collaboration & promising early Phase I AD-214 results @PSR_Insights reiterated $1AD valuation unchanged $0.30 base case & $0.57 full bull case. Read full report https://t.co/kENrNOss8c #IPF #ausbiz #biotech

[IR Department @ir_department]

Look forward to hearing from the experts & supporting the Island Pharmaceuticals team on ASEAN #Dengue Day #ausbiz $ILA #virus

[MTPConnect @MTPConnect_AUS]

.@ANDHealthAU’s 6-Day Digital Health Masterclass is underway supported by our #REDI initiative, & our Chair @SueMacLeman is joining a panel this morning to discuss 'The Importance of Governance in Managing Risk'.

[islandpharmaceuticals @IslandPharma]

Register for @IslandPharma ASEAN Dengue Day Investor Briefing - Tuesday 15th June 2021, to learn more about how $ILA is working to address the unmet medical need to fight Dengue Fever.
https://t.co/jksaU20yXr #ausbiz #dengue #ASEAN #auspol